Effects of changes in hemoglobin level on quality of life and cognitive function in inflammatory bowel disease patients
- 1 February 2006
- journal article
- research article
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 12 (2), 123-130
- https://doi.org/10.1097/01.mib.0000196646.64615.db
Abstract
Background. Anemia commonly complicates inflammatory bowel disease (IBD). In patients with chronic renal failure, the treatment of anemia with iron ± erythropoKeywords
This publication has 29 references indexed in Scilit:
- Iron supplementation for unexplained fatigue in non-anaemic women: double blind randomised placebo controlled trialBMJ, 2003
- A simple clinical colitis activity indexGut, 1998
- The Inflammatory Bowel Disease Questionnaire: A Valid and Reliable Measure in Ulcerative Colitis Patients in the North East of EnglandScandinavian Journal of Gastroenterology, 1998
- The safety of intravenous iron dextran in hemodialysis patientsAmerican Journal of Kidney Diseases, 1996
- Recombinant Erythropoietin for the Treatment of Anemia in Inflammatory Bowel DiseaseNew England Journal of Medicine, 1996
- The MOS 36-ltem Short-Form Health Survey (SF-36)Medical Care, 1992
- Issues in quality-of-life measurement in clinical trialsControlled Clinical Trials, 1991
- Improvement of brain function in hemodialysis patients treated with erythropoietinKidney International, 1990
- Generic and Disease-Specific Measures in Assessing Health Status and Quality of LifeMedical Care, 1989
- Paced Auditory Serial-Addition Task: A Measure of Recovery from ConcussionPerceptual and Motor Skills, 1977